A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
Arcturus Therapeutics (United States) · Lineage Cell Therapeutics (United States) · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
962
total citations
- FWCI
- 28.89
- Percentile
- 100%
- References
- 67
Citations per year
Authors
30- XMXiao-Jun Ma
Arcturus Therapeutics (United States), Lineage Cell Therapeutics (United States)
- ZWZuncai Wang
Harvard University, Massachusetts General Hospital
- PDPaula D. Ryan
Harvard University, Massachusetts General Hospital
- SJSteven J. Isakoff
Harvard University, Dana-Farber Cancer Institute
- ABAnne Barmettler
Harvard University, Massachusetts General Hospital
Topics & keywords
Topics
Keywords
- Tamoxifen
- Breast cancer
- Oncology
- Internal medicine
- Estrogen receptor
- Medicine
- Cancer
- Antiestrogen
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.